Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 10, Pages e25164
Publisher
Public Library of Science (PLoS)
Online
2011-10-15
DOI
10.1371/journal.pone.0025164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysis
- (2010) Sufeng Chen et al. LUNG CANCER
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation
- (2009) Koichi Azuma et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Immunodetection of DNA Repair Endonuclease ERCC1-XPF in Human Tissue
- (2009) N. R. Bhagwat et al. CANCER RESEARCH
- XPG mRNA Expression Levels Modulate Prognosis in Resected Non–Small-Cell Lung Cancer in Conjunction with BRCA1 and ERCC1 Expression
- (2009) Roberta Bartolucci et al. Clinical Lung Cancer
- Different Impact of Excision Repair Cross-Complementation Group 1 on Survival in Male and Female Patients With Inoperable Non–Small-Cell Lung Cancer Treated With Carboplatin and Gemcitabine
- (2009) Bente Holm et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy
- (2009) Hyun Woo Lee et al. LUNG CANCER
- Expression of Bcl-2 predicts outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapy
- (2009) Seong Hyun Jeong et al. LUNG CANCER
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- ERCC1expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy
- (2008) In Gyu Hwang et al. CANCER
- A re-evaluation of random-effects meta-analysis
- (2008) Julian P. T. Higgins et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY
- Excision Repair Cross Complementing-1 and Topoisomerase IIα Gene Expression in Small-Cell Lung Cancer Patients Treated with Platinum and Etoposide: A Retrospective Study
- (2008) Paolo Ceppi et al. Journal of Thoracic Oncology
- Expression of excision repair cross-complementation group 1 and class III β-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer
- (2008) Katsuhiro Okuda et al. LUNG CANCER
- Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy
- (2008) Shuji Ota et al. LUNG CANCER
- Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel
- (2008) Koichi Azuma et al. LUNG CANCER
- Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer
- (2008) Young Hak Kim et al. LUNG CANCER
- Expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with small cell lung cancer
- (2007) Hyun Woo Lee et al. LUNG CANCER
- ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
- (2007) Kyung-Hun Lee et al. LUNG CANCER
- ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer
- (2007) Tetsuya Fujii et al. LUNG CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started